| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2002 | US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them |
| 06/18/2002 | US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract |
| 06/18/2002 | US6407105 Compounds and methods for use thereof in the treatment of cancer or viral infections |
| 06/18/2002 | US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor |
| 06/18/2002 | US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 06/18/2002 | US6407101 Progesterone receptor antagonists; contraceptives, hormone replacement therapy; breast and prostate cancer treatment; menopause |
| 06/18/2002 | US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 06/18/2002 | US6407095 Treating nicotinic receptor, gastrointestinal, nervous system, psychological, and brain disorders |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407093 (3,4-dihydro-2h-benzothiopyran-4-yl)-homopiperazine derivatives; antiischemic agents; alzheimer*s and parkinson*s disease, aids related dementia, multiple sclerosis, amyotrophic lateral sclerosis |
| 06/18/2002 | US6407092 Tetracyclic azepinoindole compounds |
| 06/18/2002 | US6407091 β-lactamase inhibiting compounds |
| 06/18/2002 | US6407090 Zinc ionophores as anti-apoptotic agents |
| 06/18/2002 | US6407088 Method of analgesia |
| 06/18/2002 | US6407086 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/18/2002 | US6407085 Antiinflammatoy agents; irritable bowel disorders |
| 06/18/2002 | US6407084 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 06/18/2002 | US6407082 Prevention of ovarian cancer by administration of a vitamin D compound |
| 06/18/2002 | US6407081 Administering azobisformamide or azobisformamidine derivative to inhibit interleukins, interferons and tumor necrosis factor |
| 06/18/2002 | US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 06/18/2002 | US6407079 Inclusion compound etherified cyclodextrin; nontoxic, stability |
| 06/18/2002 | US6407078 AZT derivatives exhibiting spermicidal and anti-viral activity |
| 06/18/2002 | US6407077 Administering b-l-(-2*-azido)-2*,3*-dideoxy-5-fluorocytidine derivative; acquired immune deficiency syndromoe (aids) treatment |
| 06/18/2002 | US6407076 Adenosine analogues and related method of treatment |
| 06/18/2002 | US6407075 Administering g-linolenic acid and doxorubicin to reduce side effects from anticarcinogenic chemotherapy |
| 06/18/2002 | US6407073 Use of coumarin derivatives for the treatment of digestive tract disorders |
| 06/18/2002 | US6407071 Method and composition for treating malignant cells |
| 06/18/2002 | US6407070 Mixture containing granulation agent; therapy for kidney disease |
| 06/18/2002 | US6407065 VLA-4 antagonists |
| 06/18/2002 | US6407060 Method for enhancing functional recovery following central nervous system ischemia or trauma |
| 06/18/2002 | US6407058 Phosphorylation of serine or threonine |
| 06/18/2002 | US6406885 Plant cell transformation vectors and dna code intimin |
| 06/18/2002 | US6406839 Methods for using a plasma-like solution |
| 06/18/2002 | US6406722 Topical; mixture containing olive oil and beeswax |
| 06/18/2002 | US6406721 Salve for treating burns |
| 06/18/2002 | US6406718 Crystal form of steroid |
| 06/18/2002 | US6406715 Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles |
| 06/18/2002 | US6406714 Dry mix formulation for bisphosphonic acids |
| 06/18/2002 | US6406708 Therapeutic compositions |
| 06/18/2002 | US6406688 Method of treating sepsis and ARDS with chemokine β-4 |
| 06/18/2002 | CA2356812A1 Tnf-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/18/2002 | CA2311756C Reduction of hair growth |
| 06/18/2002 | CA2249375C Propofol microdroplet formulations |
| 06/18/2002 | CA2241725C Growth-hormone secretagogues |
| 06/18/2002 | CA2238140C Imidazole, triazole and tetrazole derivatives |
| 06/18/2002 | CA2235053C Novel amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and 2,3-dihydro-cyclopenta[e]indene, process for their preparation and pharmaceutical compositions containing them |
| 06/18/2002 | CA2219603C Method of stimulating gastrointestinal motility with ellagic acid |
| 06/18/2002 | CA2191850C Cancerous metastasis inhibitor |
| 06/18/2002 | CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace |
| 06/18/2002 | CA2057697C Anticalculus oral composition |
| 06/18/2002 | CA2029657C Compositions and their use in lowering intraocular pressure |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/14/2002 | WO2001041709A2 Methods for treating cell death diseases and inflammation |
| 06/14/2002 | CA2393722A1 Methods for treating cell death diseases and inflammation |
| 06/14/2002 | CA2350347A1 Cosmetic composition |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | WO2002046424A2 Fibroblast growth factors |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046415A2 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 06/13/2002 | WO2002046241A2 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002046239A1 Thermoplastic and water soluble cellulose ether esters |
| 06/13/2002 | WO2002046224A2 Compositions and methods relating to lung specific genes and proteins |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046204A1 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials |
| 06/13/2002 | WO2002046203A1 A substance or composition for the treatment of cancer |
| 06/13/2002 | WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | WO2002046196A1 Process for the isolation and purification of epothilones |
| 06/13/2002 | WO2002046194A2 Substituted imidazopyridines |
| 06/13/2002 | WO2002046193A2 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046192A2 Thioether substituted imidazoquinolines |
| 06/13/2002 | WO2002046191A2 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | WO2002046190A2 Sulfonamido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046189A2 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046188A2 Amido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046186A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046180A1 Klainetin and derivatives thereof, method for their production and the use of the same |
| 06/13/2002 | WO2002046178A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 06/13/2002 | WO2002046177A1 A process for the preparation of paclitaxel |
| 06/13/2002 | WO2002046173A1 Fused heteroaromatic glucokinase activators |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046169A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | WO2002046168A1 Therapeutic benzimidazole compounds |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 06/13/2002 | WO2002046164A1 Therapeutic compounds |
| 06/13/2002 | WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 06/13/2002 | WO2002046161A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | WO2002046160A2 Process for making a thrombin inhibitor |
| 06/13/2002 | WO2002046159A1 Guanidine and amidine derivatives as factor xa inhibitors |
| 06/13/2002 | WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase |